Cardiac Fibrosis Repurposing Pipeline
Genetically Defined Heart Failure (Cardiac Fibrosis)
Key Facts
About InvivoSciences
InvivoSciences is a private, preclinical-stage biotech founded in 2008 and based in Madison, Wisconsin. The company has developed a proprietary, automated platform for generating and functionally testing patient-derived 3D micro-heart tissues, positioning itself as both a technology provider for pharmaceutical partners and a therapeutics developer. Its core value proposition is using human-relevant, physiologically complex tissue data to improve the predictability of drug efficacy and safety, particularly for heart failure and cardiotoxicity, thereby aiming to reduce the high cost and failure rate of clinical trials. The company appears to be pre-revenue, supported by grants and investors.
View full company profile